Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hemophilia A
Related studies linked through entity extraction aliases.
Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy
- Status
- UNKNOWN
- Phase
- N/A
A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Status
- RECRUITING
- Phase
- PHASE3
Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE1
Prophylaxis Regimen for Hemophilia A Patients
- Status
- COMPLETED
- Phase
- PHASE4
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Status
- RECRUITING
- Phase
- N/A
A Study of ADVATE in People With Hemophilia A in India
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A
- Status
- COMPLETED
- Phase
- N/A
A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.
- Status
- COMPLETED
- Phase
- N/A
A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate
- Status
- COMPLETED
- Phase
- N/A
Association Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active Conditions
- Status
- UNKNOWN
- Phase
- N/A
Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
- Status
- RECRUITING
- Phase
- N/A
Intensive Replacement Treatment in Haemophilia Patients With Synovitis
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)
- Status
- COMPLETED
- Phase
- N/A
Gene Therapy for Chinese Hemophilia A
- Status
- RECRUITING
- Phase
- NA
Health Related Quality of Life of Youth and Young Adults With Haemophilia A
- Status
- COMPLETED
- Phase
- PHASE4
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
- Status
- WITHDRAWN
- Phase
- PHASE4